Keros Therapeutics (KROS) Market Capitalization (2020 - 2026)
Keros Therapeutics (KROS) reported Market Capitalization of $212.15 million for Q2 2026, down 60.9% from $542.22 million a year earlier.
Powered by 
Analysis
Keros Therapeutics (KROS) Market Capitalization (2020 - 2026) Analysis & Trends
For FY2025, Keros Therapeutics posted Market Capitalization of $757.82 million, up 18.0% from FY2024.
- Market Capitalization has a five-year compound annual growth rate of -7.1% (FY2020 to FY2025).
- By year, Market Capitalization came in at $641.98 million in FY2024 (-49.3%), $1.27 billion in FY2023 (-4.3%), $1.32 billion in FY2022 (-5.7%) and $1.4 billion in FY2021 (+28.2%).
- The Q2 2026 figure ranks as the lowest quarterly Market Capitalization in data going back to Q2 2020.
- Year over year, Market Capitalization gained in two of the last seven quarters, with an average decline of 24.7%.
- The high point for year-over-year Market Capitalization in five years was Q3 2024 (growth of 140.9%); the low point was Q1 2025 (a decline of 82.7%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Keros Therapeutics | 185.02 Mn | -900.96 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 226.07 Mn |
| Jun 30, 2026 | 212.15 Mn |
| Mar 31, 2026 | 217.85 Mn |
| Dec 31, 2025 | 757.82 Mn |
| Sep 30, 2025 | 642.80 Mn |
| Jun 30, 2025 | 542.22 Mn |
| Mar 31, 2025 | 413.33 Mn |
| Dec 31, 2024 | 641.98 Mn |
| Sep 30, 2024 | 2.28 Bn |
| Jun 30, 2024 | 1.65 Bn |
| Mar 31, 2024 | 2.39 Bn |
| Dec 31, 2023 | 1.27 Bn |
| Sep 30, 2023 | 946.17 Mn |
| Jun 30, 2023 | 1.19 Bn |
| Mar 31, 2023 | 1.26 Bn |
| Dec 31, 2022 | 1.32 Bn |
| Sep 30, 2022 | 981.02 Mn |
| Jun 30, 2022 | 674.98 Mn |
| Mar 31, 2022 | 1.31 Bn |
| Dec 31, 2021 | 1.40 Bn |
API Access
Keros Therapeutics Market Capitalization API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=market-capitalization&ticker=KROS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "market-capitalization", "ticker": "KROS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=market-capitalization&ticker=KROS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();